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Historical landmarks in dementia with Lewy bodies 
 
Author’s accepted manuscript  
(for formal article:  http://dx.doi.org/10.1016/S1474-4422(17)30089-3) 
 
Fritz Jakob Heinrich Lewy (1885–1950) described the eosinophilic intraneuronal inclusion 
bodies, which were later named after him, while studying the neuropathology of Parkinson’s 
disease at Alois Alzheimer’s laboratory in Munich, Germany, in 1912.1 
In 1962, John Woodard, neuropathologist at the Camarillo State Hospital in California, US, 
reported a wide range of neuropsychiatric symptoms and cognitive decline in 27 patients with 
autopsy proven Lewy body disease, of whom only about a quarter had parkinsonian 
symptoms.2 Over the following decades, Kenji Kosaka (Yokohama City University) and 
other researchers from Japan reported detailed autopsies of more than twenty patients with a 
variable distribution of Lewy bodies in their brain stem and cerebral cortex, who clinically 
presented with varying amounts of cognitive impairment, neuropsychiatric, and motor 
symptoms.3 Aggregated α-synuclein was shown to be the key component of Lewy bodies in 
the 1990s1 and the first international workshop on the disease held in Newcastle in 1995 
proposed the term “dementia with Lewy bodies”. Diagnostic criteria were published, 
including the three core features of fluctuation in cognitive function, visual hallucinations, 
and spontaneous motor features of parkinsonism.4 The criteria were revised in 2005, 
featuring the introduction of suggestive features (Rapid eye movement sleep behavioural 
disorder, severe neuroleptic sensitivity, and low dopamine transporter uptake in basal 
ganglia) and a temporal criterion which distinguishes dementia with Lewy bodies from 
dementia in Parkinson’s disease.5 In 2013, dementia with Lewy bodies was included in the 
Diagnostic and Statistical Manual of Mental Disorders, fifth edition, and we hope that 
dementia with Lewy bodies will be acknowledged as a separate entity in the International 
Classification of Diseases, 11th revision. 
 
Christoph Mueller, Clive Ballard, Anne Corbett, Dag Aarsland 
 
References:  
1 Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy 
pathology. Nat Rev Neurol 2013; 9: 13–24. 
2 Woodard JS. Concentric hyaline inclusion body formation in mental 
disease analysis of twenty-seven cases. J Neuropathol Exp Neurol 1962; 
21: 442–49. 
3 Kosaka K. Latest concept of Lewy body disease. Psychiatry Clin Neurosci 
2014; 68: 391–94. 
4 McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical 
and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 
1996; 47: 1113–24. 
5 McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of 
dementia with Lewy bodies: third report of the DLB Consortium. Neurology 
2005; 65: 1863–72. 
